2002
DOI: 10.1016/s0960-0760(01)00174-1
|View full text |Cite
|
Sign up to set email alerts
|

Oestrogenic activity of parabens in MCF7 human breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

12
250
1
10

Year Published

2004
2004
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 333 publications
(273 citation statements)
references
References 39 publications
12
250
1
10
Order By: Relevance
“…Concern in regard to the safety of parabens has been raised since the first report of the accumulation of MeP in human breast tumors (Darbre et al, 2004). Although controversy still surrounds the carcinogenic potential of parabens (Darbre et al, 2004;Golden et al, 2005), these compounds elicit weak estrogenic effects in animal studies (Byford et al, 2002;Darbre and Harvey, 2008;Lemini et al, 2003;Miller et al, 2001;Okubo et al, 2001;Pugazhendhi et al, 2005;Witorsch and Thomas, 2010). The estrogenic activity of parabens increases with the length of the alkyl chain; MeP, EtP, PrP, and BuP exhibit estrogenic potencies that are 2 500 000-, 150 000-, 30 000-, and 10 000-fold, respectively, less than that of 17β-estradiol (Routledge et al, 1998).…”
Section: Introductionmentioning
confidence: 99%
“…Concern in regard to the safety of parabens has been raised since the first report of the accumulation of MeP in human breast tumors (Darbre et al, 2004). Although controversy still surrounds the carcinogenic potential of parabens (Darbre et al, 2004;Golden et al, 2005), these compounds elicit weak estrogenic effects in animal studies (Byford et al, 2002;Darbre and Harvey, 2008;Lemini et al, 2003;Miller et al, 2001;Okubo et al, 2001;Pugazhendhi et al, 2005;Witorsch and Thomas, 2010). The estrogenic activity of parabens increases with the length of the alkyl chain; MeP, EtP, PrP, and BuP exhibit estrogenic potencies that are 2 500 000-, 150 000-, 30 000-, and 10 000-fold, respectively, less than that of 17β-estradiol (Routledge et al, 1998).…”
Section: Introductionmentioning
confidence: 99%
“…Many cosmetic products, including antiperspirants, contain parabens that can be dermally absorbed. Parabens have estrogen-like properties in cell cultures, causing proliferation of estrogen-responsive cells, although they are thousands of times less potent than naturally-occurring estrogen in this regard [164][165][166]. Parabens were found to activate both estrogen receptors, ER-α and ER-β, with similar or stronger effect versus ER-β receptors [165,167,168].…”
Section: Parabensmentioning
confidence: 99%
“…Competitive inhibition of 17β-estradiol binding to estrogen-dependent MCF7 cell ERs could be detected at 1,000,000-fold molar excess of butylparaben (BuP, 86%), propylparaben (PrP, 77%), ethylparaben (EtP, 54%) and methylparaben (MeP, 21%). Molecular modelling has indicated the mode by which paraben molecules can bind into the ligand binding pocket of the crystal structure of the ligand binding domain of ER-α in place of 17β-estradiol, and it has been shown that two paraben molecules can bind simultaneously in a mode, in which their phenolic hydroxyl groups bind similarly to those of the hexestrol molecule [164].…”
Section: Parabensmentioning
confidence: 99%
“…Parabens can mimic estrogen action stimulating the growth of MCF7 cells, which are related to the development of breast cancer. 4,5 Parabens at trace levels have been determined in several biological matrices, such as urine, 2,6 breast milk, [7][8][9][10][11] plasma, 12 serum, 13 amniotic fluid, 14 and placental tissue. 15,16 As known, lipophilic substances are mainly excreted in breast milk, and consequently, that breast milk is the major way through which breastfed infants are exposed to environmental chemicals.…”
Section: Introductionmentioning
confidence: 99%